APPLICATION
NDA020161
TYPE
NDA
ORIGINAL APPROVAL
1992-11-30
LATEST ACTION
2002-11-01
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription, Discontinued
Products
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER · ReferencePrescription
POTASSIUM CHLORIDE 29.8MG/ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER · ReferencePrescription
POTASSIUM CHLORIDE 2.98GM/100ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER · ReferencePrescription
POTASSIUM CHLORIDE 1.49GM/100ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER · ReferencePrescription
POTASSIUM CHLORIDE 14.9MG/ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER · ReferenceDiscontinued
POTASSIUM CHLORIDE 2.24GM/100ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER · ReferencePrescription
POTASSIUM CHLORIDE 745MG/100ML · INJECTABLE · INJECTION
Approval history
2002-11-01Manufacturing (CMC) · Supplement 10 · standardAP
2001-07-30Manufacturing (CMC) · Supplement 9 · standardAP
1999-09-24Labeling · Supplement 4AP
1998-08-11Labeling · Supplement 8AP
1998-08-11Manufacturing (CMC) · Supplement 6 · standardAP
1998-08-11Manufacturing (CMC) · Supplement 7 · standardAP
1998-08-11Manufacturing (CMC) · Supplement 5 · standardAP
1996-08-27Manufacturing (CMC) · Supplement 3 · standardAP
1994-08-05Manufacturing (CMC) · Supplement 1 · standardAP
1994-05-24Labeling · Supplement 2AP
1992-11-30Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.